Oocysts identification
Five Eimeria species were identified based on the morphological characteristics of sporulated oocysts: E. acervulina (39%), E. tenella (23%), E. mitis (15%), E. maxima (14%), and E. brunetti (9%). The predominance of E. acervulina and E. tenella aligns with previous findings reported in various regions of Algeria. Djemai et al. (Djemai et al., 2016) reported E. acervulina and E. maxima as the most prevalent species in poultry farms in the Jijel region. In Sétif, E. tenella was the most frequently detected species (68%), followed by E. mitis (10%) and E. acervulina (14%) (Sabrina, 2021). A similar distribution pattern was described by Rahmani et al. (Rahmani et al., 2021), who recorded E. acervulina (35%), E. tenella (30%), E. maxima (15%), E. brunetti (12%), and E. mitis (8%).
Phytochemical Characterization of OFI-SO and OFI-HexPC by GC–MS
GC–MS analysis of OFI-SO revealed that fatty acids constituted 91.33% of its total composition (Table 1; Fig. 1). Linoleic acid was the dominant component (69.63%), followed by palmitic (10.28%) and stearic (6.88%) acids. Several minor constituents were also detected, including palmitoleic (0.41%), gadoleic (0.47%), arachidic (0.90%), erucic (0.48%), behenic (0.49%), and lignoceric (0.34%) acids.
The fatty acid profile of OFI-HexPC differed considerably (Table 2; Fig. 2), with oleic acid being the predominant fatty acid (44.20%), followed by palmitic (19.02%) and stearic (10.15%) acids. Minor quantities of gadoleic (2.65%), arachidic (2.99%), and nonadecenoic (2.11%) acids were identified, alongside trace amounts of erucic, behenic, and lignoceric acids.
These findings are broadly consistent with previous analyses of Algerian Opuntia ficus-indica oils. Benattia et al. reported lower linoleic acid content (60.23%) and higher proportions of palmitic (14.2%) and oleic acids (13.35%) (Benattia et al., 2019). In contrast, Chafaa et al. found a higher linoleic acid level (74.24%) with a comparable stearic acid proportion (6.75%) (Chafaa et al., 2024). Abderrahmane et al. observed 62.63% linoleic acid and significantly more oleic acid (20.36%) (Bouaouich et al., 2023). Such variation is likely due to genetic background, environmental conditions, and extraction techniques.
Outside Algeria, comparable values have been reported. An Iraqi variety displayed slightly higher linoleic acid content (72.90%) and greater palmitic acid proportion (15.12%) (Alsaad et al., 2019). A recent study from Saudi Arabia showed a fatty acid composition similar to the present work, reinforcing the general lipid stability of O. ficus-indica across arid regions (Alqurashi et al., 2022). In Tunisian samples, linoleic acid was again the major constituent (60.69%), followed by oleic (16.41%), palmitic (12.72%), stearic (3.20%), and palmitoleic (0.75%) acids(BORCHANI, 2022).
In contrast, Moroccan OFI-HexPC was reported to contain only four main fatty acids: linoleic (37.21%), palmitic (29.9%), oleic (27.16%), and stearic (5.92%) (Kadda et al., 2023), highlighting the significant impact of regional and varietal factors on seed cake composition.
Both OFI-SO and OFI-HexPC share several key fatty acids, though their relative abundances differ. Linoleic acid, a polyunsaturated fatty acid (PUFA), is widely recognized for its hypocholesterolemic, anti-inflammatory, and skin-protective properties, supporting its broad industrial relevance (Ramadan and Mörsel, 2003; Kadda et al., 2023). Palmitic acid, a saturated fatty acid, is associated with increased LDL cholesterol (Djeghim et al., 2024), whereas stearic acid has a neutral or potentially beneficial impact on lipid metabolism (Tong et al., 2020). These biochemical characteristics, combined with the high content of unsaturated fatty acids, suggest that both extracts may hold nutritional, pharmaceutical, and anticoccidial potential.
Table 1
Volatile compounds identified by GC-MS in OFI-SO
peak | Retention Time RT (min) | Area % | Library/ID* | Molecules | Formule |
|---|
1 | 24,53 | 0,41 | Hexadecenoic acid | Palmetoleic acid | C16 :1(9) |
2 | 25,05 | 10,28 | Hexadecanoic acid | Palmetic acid | C16 :0 |
3 | 30,2 | 69,63 | Octadecadienoic acid | Linoleic acid | C18 :2(9,12) |
4 | 30,97 | 6,88 | Octadecanoic acid | Stearic acid | C18 :0 |
5 | 35,66 | 0,47 | Eicosenoic acid | Gadolic acid | C20 :1(9) |
6 | 36,46 | 0,9 | Eicosanoic acid | Arachidic acid | C20 :0 |
7 | 41,1 | 0,48 | 13-Docosenoic acid | Erucic acid | C22 :1(13) |
8 | 41,62 | 0,49 | Docosanoic acid | Behenic acid | C22 :0 |
9 | 47,27 | 0,34 | Tetracosanoic acid | Lignoceric acid | C24 :0 |
10 | 54,32 | 1,45 | Stigmastan 3.5diene | | |
| *NIST 2 |
Table 2
Volatile compounds identified by GC-MS in OFI-HexPC
PEAK | RT | Area % | Library/ID* | Molecules | Formula |
|---|
1 | 19,1 | 0,75 | Nonanoic acid | Nonanoic acid | C9 :0 |
2 | 20,23 | 0,02 | Dodecenoic acid | Lauroleic acid | C12 :1 |
3 | 23,47 | 0,08 | Tetradecenoic acid | Myristoleic acid | C14 :1 |
4 | 24,53 | 0,86 | Hexadecenoic acid | Palmetoleic acid | C16 :1(9) |
5 | 25,05 | 14,86 | Hexadecacanoic acid | Palmetic acid | C16 :0 |
6 | 28,1 | 0,2 | Tridecanoic acid | Tridecanoic acid | C13 :0 |
7 | 30,37 | 44,2 | Octadecenoic acid | Oleic acid | C18 :1 |
8 | 30,97 | 7,98 | Octadecanoic acid | Stearic acid | C18 :0 |
9 | 32,97 | 0,23 | Undecanoic acid | Undecanoic acid | C11 :0 |
10 | 34,76 | 0,68 | Carbonic acid | Carbonic acid | C1 |
11 | 35,66 | 2,65 | Eicosenoic acid | Gadolic acid | C20 :1(9) |
12 | 36,46 | 2,99 | Eicosanoic acid | Arachidic acid | C20 :0 |
13 | 37,19 | 2,11 | Nonadecenoic acid | Nonadecenoic acid | C19 :1 |
14 | 41,1 | 0,55 | 13-Docosenoic acid | Erucic acid | C22 :1(13) |
15 | 41,62 | 1,21 | Docosanoic acid | Behenic acid | C22 :0 |
16 | 44,63 | 0,28 | Butanoic acid | Butanoic acid | C4 |
17 | 47,27 | 0,22 | Tetracosanoic acid | Lignoceric acid | C24 :0 |
18 | 49,52 | 0,11 | Pentacosanoic acid | Pentacosanoic acid | C15 :0 |
19 | 54,32 | 0,11 | Stigmastan 3.5diene | | |
| *NIST 2 |
In Vitro Anticoccidial Activity of OFI-SO and OFI-HexPC
In vitro assays revealed a clear, concentration-dependent destructive effect on Eimeria spp. oocysts following treatment with OFI-SO, OFI-HexPC, and the synthetic anticoccidial agent Toltrazuril (Fig. 3). Both extract type and concentration had statistically significant effects on oocyst counts and the release of absorbent intracellular material (p < 0.001), with a significant interaction between these factors (p < 0.001; Tables 3 and 4). This dose-dependent effect was further confirmed by the progressive increase in absorbance at 273 nm (Fig. 4), indicative of membrane disruption and cytoplasmic leakage. No such effects were observed in the negative control group (HBSS).
Table 3
Two-way ANOVA results for Parasite Numbers
Source | df | SS | MS | F | P | Significance |
|---|
Extract Type | 2 | 901.45 | 450.72 | 3141.07 | < 0.001 | *** |
Concentration | 6 | 70.61 | 11.77 | 82.02 | < 0.001 | *** |
Extract Type: Concentration | 12 | 49.80 | 4.15 | 28.92 | < 0.001 | *** |
Residuals | 42 | 6.03 | 0.14 | | NA | |
| df: Degree of Freedom, SS, Sum Square, MS: Mean Square, * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant |
Table 4
Two-way ANOVA results for Material Absorbance
Source | Df | SS | MS | F | p | Significance |
|---|
Extract Type | 2 | 0.51 | 0.26 | 277.65 | < 0.001 | *** |
Concentration | 6 | 1.16 | 0.19 | 209.38 | < 0.001 | *** |
Extract Type: Concentration | 12 | 0.55 | 0.05 | 50.05 | < 0.001 | *** |
Residuals | 42 | 0.04 | 0.00 | | NA | |
| df: Degree of Freedom, SS, Sum Square, MS: Mean Square, * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant |
Post hoc comparisons demonstrated that OFI-HexPC consistently exhibited lower efficacy than both OFI-SO and Toltrazuril across all tested concentrations (p < 0.001). By contrast, OFI-SO showed similar levels of efficacy to Toltrazuril (p = 1.000), particularly at higher concentrations. Absorbance data confirmed these findings: while no significant differences were observed between treatments at low concentrations (0–4 mg/mL), OFI-HexPC’s performance was significantly reduced at 8–64 mg/mL compared to OFI-SO and the positive control (Tables 5 and 6). A strong negative correlation between oocyst counts and absorbance (Table 7; Fig. 5) supports a mechanism involving membrane damage.
Table 5
Tukey’s HSD for Parasite Numbers across Extract Types at each Concentration
Contrast | Concentration | Estimate | SE | Df | t.ratio | p.value |
|---|
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C1 | 11.20 | 0.31 | 42 | 36.21 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C1 | 11.20 | 0.31 | 42 | 36.21 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C1 | 0.00 | 0.31 | 42 | 0.00 | 1.000 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C2 | 9.10 | 0.31 | 42 | 29.42 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C2 | 9.10 | 0.31 | 42 | 29.42 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C2 | 0.00 | 0.31 | 42 | 0.00 | 1.000 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C3 | 9.10 | 0.31 | 42 | 29.42 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C3 | 9.10 | 0.31 | 42 | 29.42 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C3 | 0.00 | 0.31 | 42 | 0.00 | 1.000 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C4 | 8.30 | 0.31 | 42 | 26.84 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C4 | 8.30 | 0.31 | 42 | 26.84 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C4 | 0.00 | 0.31 | 42 | 0.00 | 1.000 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C5 | 7.30 | 0.31 | 42 | 23.60 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C5 | 7.30 | 0.31 | 42 | 23.60 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C5 | 0.00 | 0.31 | 42 | 0.00 | 1.000 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C6 | 5.60 | 0.31 | 42 | 18.11 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C6 | 5.60 | 0.31 | 42 | 18.11 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C6 | 0.00 | 0.31 | 42 | 0.00 | 1.000 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C7 | 5.57 | 0.31 | 42 | 18.02 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C7 | 5.57 | 0.31 | 42 | 18.00 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C7 | -0.01 | 0.31 | 42 | -0.02 | 1.000 |
| SE: Standard Error, df: Degree of Freedom |
Table 6
Tukey’s HSD for Material Absorbance across Extract Types at each Concentration
Contrast | Concentration | Estimate | SE | Df | t.ratio | p.value |
|---|
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C1 | 0.00 | 0.025 | 42 | 0.00 | 1.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C1 | 0.00 | 0.025 | 42 | 0.00 | 1.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C1 | 0.00 | 0.025 | 42 | 0.00 | 1.000 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C2 | -0.03 | 0.025 | 42 | -1.21 | 0.700 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C2 | -0.04 | 0.025 | 42 | -1.41 | 0.497 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C2 | -0.01 | 0.025 | 42 | -0.20 | 1.000 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C3 | -0.02 | 0.025 | 42 | -0.76 | 1.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C3 | -0.04 | 0.025 | 42 | -1.77 | 0.252 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C3 | -0.03 | 0.025 | 42 | -1.01 | 0.958 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C4 | 0.25 | 0.025 | 42 | 10.08 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C4 | 0.22 | 0.025 | 42 | 9.07 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C4 | -0.03 | 0.025 | 42 | -1.01 | 0.958 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C5 | 0.27 | 0.025 | 42 | 10.89 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C5 | 0.25 | 0.025 | 42 | 10.08 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C5 | -0.02 | 0.025 | 42 | -0.81 | 1.000 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C6 | 0.48 | 0.025 | 42 | 19.15 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C6 | 0.43 | 0.025 | 42 | 17.13 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C6 | -0.05 | 0.025 | 42 | -2.02 | 0.151 |
EXTRACT 1(OFI-HexPC) - EXTRACT 2(OFI-SO) | C7 | 0.47 | 0.025 | 42 | 19.08 | 0.000 |
EXTRACT 1(OFI-HexPC) - POSITIVE CONTROL | C7 | 0.42 | 0.025 | 42 | 16.93 | 0.000 |
EXTRACT 2(OFI-SO) - POSITIVE CONTROL | C7 | -0.05 | 0.025 | 42 | -2.15 | 0.112 |
| SE: Standard Error, df: Degree of Freedom |
Table 7
Pearson correlation between Parasite Numbers and Material Absorbance by Extract Type
Extract Type | Pearson_r | t_value | df | p_value | CI_lower | CI_upper |
|---|
EXTRACT 1(OFI-HexPC) | -0.923 | -10.493 | 19.000 | 0.000 | -0.969 | -0.818 |
EXTRACT 2(OFI-SO) | -0.804 | -5.903 | 19.000 | 0.000 | -0.918 | -0.571 |
POSITIVE CONTROL | -0.890 | -8.515 | 19.000 | 0.000 | -0.955 | -0.745 |
| df: Degree of Freedom, CI: Confidence Interval |
The dose-response curves (Figs. 6 and 7) indicated that all tested compounds exhibited concentration-dependent effects on both parameters. Toltrazuril demonstrated the highest potency with an LC₅₀ of 47.00 mg/mL. Among the plant-derived compounds, OFI-SO showed slightly higher activity (LC₅₀ = 47.05 mg/mL) compared to OFI-HexPC (LC₅₀ = 50.09 mg/mL), confirming the superior activity of OFI-SO among the plant-derived treatments.
These results align with prior investigations on Opuntia ficus-indica extracts, where peel and flower fractions demonstrated lower efficacy (LC₅₀ = 60.53 mg/mL and 66.04 mg/mL, respectively) (Amrane-Abider et al., 2023a, b). By comparison, Pistacia lentiscus oil showed a substantially lower LC₅₀ (5.86 mg/mL), suggesting higher antiparasitic potency (Rahmani et al., 2021). Other plant-based products, such as olive leaf extracts, yielded varied results, with LC₅₀ values ranging from 14.88 to 194.92 mg/mL depending on the bioactive component (Debbou-Iouknane et al., 2021). Variability in experimental protocols, Eimeria species, and extract composition likely account for these differences.
The potent activity observed for OFI-SO and OFI-HexPC is likely due to their high content of unsaturated fatty acids, particularly linoleic and oleic acids, as confirmed by GC–MS. These compounds are known to exhibit anti-protozoal activity, often through disruption of parasite membrane integrity and interference with ion transport (Ismaeil et al., 2025; Liu et al., 2025). The increased absorbance at 273 nm in treated groups suggests leakage of nucleotides and aromatic amino acids—typical indicators of cell lysis (Remmal et al., 2011).
These findings are further supported by similar effects reported in other parasitic systems. PUFAs such as docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and arachidonic acid (AA) have demonstrated inhibitory activity against Plasmodium falciparum, disrupting schizont development and inhibiting nucleic acid synthesis (Kumaratilake et al., 1992; Krugliak et al., 1995). In helminths like Schistosoma mansoni, AA induced tegumental disintegration through sphingomyelinase activation, resulting in exposure of parasitic antigens (El Ridi et al., 2012). Comparable membrane-disruptive effects were also noted in oocysts exposed to plant extracts, leading to loss of cytoplasmic mass and parasite death (Abbas et al., 2019).
Taken together, these data suggest that OFI-SO and OFI-HexPC exert their anticoccidial effects through a combination of membrane disruption and intracellular destabilization. These preliminary findings justify further mechanistic investigation through molecular docking and in vivo validation.
Molecular Docking Analysis
To elucidate the molecular mechanisms underlying the anticoccidial activity observed in vitro, molecular docking simulations were conducted on three key enzymes: dihydroorotate dehydrogenase (EtDHODH; PDB: 6AJE), calcium-dependent protein kinase (CDPK; PDB: 4YZB), and cAMP-dependent protein kinase A (PKA; PDB: 4WB5). These targets are critical to pyrimidine biosynthesis, intracellular signaling, and host cell invasion, and are widely recognized as relevant targets for anticoccidial drug discovery (Haste et al., 2012; Sato et al., 2020; Aljedaie et al., 2021).
The docking protocol was validated through redocking of the native ligands into their respective binding sites. The resulting RMSD values—1.018 Å for 4YZB, 0.861 Å for 4WB5, and 1.086 Å for 6AJE—demonstrated excellent overlap with crystallographic poses, confirming the reliability of the docking simulations.
Docking results (Figs. 8–11) showed that Diclazuril exhibited the strongest binding affinities, particularly with CDPK (–8.2 kcal/mol), followed by Toltrazuril (–7.7 kcal/mol). Diclazuril formed multiple hydrogen bonds (e.g., TYR339, SER340, TYR98) and hydrophobic interactions (e.g., ILE342, LEU70, LEU80). Toltrazuril displayed strong interactions through hydrogen bonds (GLY317, SER287, THR95), hydrophobic contacts (CYS111, LEU148, LYS50), and halogen bonding, which may enhance its target binding stability.
Among the fatty acids identified in OFI-SO and OFI-HexPC, linoleic, oleic, palmitic, and stearic acids displayed moderate binding energies (–5.4 to − 6.5 kcal/mol). These values are consistent with other phytochemicals such as apigenin (–6.44 kcal/mol) and artemisinin (–5.83 kcal/mol) (Aljedaie et al., 2021). The binding modes were predominantly stabilized by hydrophobic interactions within the active sites, suggesting a potential for partial enzymatic inhibition.
Although the fatty acids exhibited weaker binding affinities than synthetic anticoccidials, their interaction profiles support a plausible mechanism of enzymatic interference, complementing the membrane-disruptive effects observed in vitro. In particular, linoleic acid demonstrated consistent binding behavior across all three targets and may significantly contribute to the dual anticoccidial action of OFI-SO and OFI-HexPC.
These findings support the hypothesis that the anticoccidial effects of Opuntia ficus-indica seed-derived extracts arise from a synergistic mechanism involving both structural damage to oocyst membranes and targeted inhibition of key parasite enzymes.
Analysis of ADMET Properties
The ADMET analysis (Table 8) highlights that Diclazuril and Toltrazuril, used as reference anticoccidial drugs, display favorable pharmacokinetic properties but also present notable toxicological risks. Toltrazuril shows high respiratory toxicity and hormonal receptor interaction, while Diclazuril exhibits marked neurotoxicity, carcinogenic potential, and thyroid receptor binding. These toxic effects raise concerns about their safety for prolonged use in animals.
In contrast, the fatty acids evaluated in this study, linoleic, oleic, palmitic, and stearic acids, derived from OFI-SO and OFI-HexPC, demonstrate a favorable ADMET profile. They do not show hepatotoxicity, neurotoxicity, respiratory toxicity, carcinogenic activity, or cytochrome P450 inhibition. While only palmitic acid crosses the blood-brain barrier, all compounds display acceptable bioavailability and pharmacokinetic behavior. In addition to their low toxicity, these fatty acids showed notable biological activity in molecular docking analyses, reinforcing their potential as natural, safer anticoccidial agents. Their ability to target specific molecular pathways, combined with good tolerability, supports their inclusion in the development of alternative therapeutic formulations.
Table 8
Analysis of ADMET Properties and Toxicity Comparison: Toltrazuril, Diclazuril, and Fatty Acids
| | Molcule | Toltrazuril | Diclazuril | Linoleic Acid | Oleic Acid | Palmitic Acid | Stearic Acid |
|---|
Physicochemical Properties | MW | 425.38 | 346.38 | 280.45 | 282.46 | 256.42 | 284.48 |
Csp3 | 0.17 | 0.2 | 0.72 | 0.83 | 0.94 | 0.94 |
NRB | 5 | 3 | 14 | 15 | 14 | 16 |
NHA | 7 | 4 | 2 | 2 | 2 | 2 |
NHD | 1 | 1 | 1 | 1 | 1 | 1 |
TPSA | 111.39 | 91.54 | 37.3 | 37.3 | 37.3 | 37.3 |
Lipophilicity | Log P | 3.64 | 2.75 | 2.75 | 4.57 | 4.19 | 4.67 |
Water Solubility | Log S | Moderately | Moderately | Moderately | Moderately | Moderately | Moderately |
Pharmacokinetics | HIA | High | High | High | High | High | High |
BBB | No | No | No | No | Yes | No |
Drug-likeness | Lipinski | 0 | 0 | 0 | 1 | 1 | 1 |
Ghose | 0 | 0 | 0 | 1 | 0 | 1 |
Veber | 0 | 0 | 0 | 1 | 1 | 1 |
Egan | 0 | 0 | 0 | 1 | 0 | 1 |
Muegge | 0 | 0 | 0 | 1 | 1 | 2 |
Medicinal Chemistry | PAINS | 0 | 0 | 0 | 0 | 0 | 0 |
Organ toxicity | Hepatotoxicity | Active (0.67) | Active (0.53) | Inactive (0.55) | Inactive (0.55) | Inactive (0.52) | Inactive (0.52) |
Neurotoxicity | Active (0.73) | Active (0.88) | Inactive (0.91) | Inactive (0.91) | Inactive (0.92) | Inactive (0.92) |
Respiratory toxicity | Active (0.75) | Active (0.56) | Inactive (0.84) | Inactive (0.84) | Inactive (0.85) | Inactive (0.85) |
Toxicity end points | Carcinogenicity | Active (0.5) | Active (0.5) | Inactive (0.64) | Inactive (0.64) | Inactive (0.63) | Inactive (0.63) |
THRβ | Inactive (0.61) | Active (0.66) | Inactive (0.91) | Inactive (0.78) | Inactive (0.78) | Inactive (0.9) |
Clinical toxicity | Active (0.61) | Active (0.58) | Inactive (0.61) | Inactive (0.61) | Inactive (0.64) | Inactive (0.64) |
Metabolism | CYP1A2 | Inactive (0.69) | Inactive (0.64) | Inactive (0.91) | Inactive (0.91) | Inactive (0.84) | Inactive (0.84) |
CYP2C19 | Inactive (0.78) | Inactive (0.9) | Inactive (0.98) | Inactive (0.98) | Inactive (0.98) | Inactive (0.98) |
CYP2C9 | Inactive (0.57) | Inactive (0.65) | Inactive (0.69) | Inactive (0.69) | Inactive (0.71) | Inactive (0.71) |
CYP2D6 | Inactive (0.8) | Inactive (0.86) | Inactive (0.88) | Inactive (0.88) | Inactive (0.88) | Inactive (0.88) |
CYP3A4 | Inactive (0.58) | Inactive (0.88) | Inactive (1.0) | Inactive (1.0) | Inactive (1.0) | Inactive (1.0) |
CYP2E1 | Inactive (0.99) | Inactive (1.0) | Inactive (0.99) | Inactive (0.99) | Inactive (0.99) | Inactive (0.99 |
| MW =Molecular Weight below 500, NHA=Num. H−bond Acceptors, NHD=Num. H−bond donors, NRB=Num. rotatable bonds, Fsp3 =Fraction Csp3 acceptors, HIA= Human Intestinal Absorption, CYP= Cytochrome P450, BBB = Blood−Brain Barrier, PAINS=Pan Assay Interference compounds or frequent hitters or promiscuous compounds, Log P: logarithm of the compound partition coefficient between n−octanol and water (− 2 to 5), TPSA= Polar surface area (0–140), THRβ =Thyroid hormone receptor bet |